Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Researchers Use Natural-Language Processing (NLP) Algorithms to Predict SARS-CoV-2 Virus Mutations

By LabMedica International staff writers
Posted on 18 Jan 2021
Natural-language processing (NLP) algorithms are now able to generate protein sequences and predict virus mutations, including key changes that help the SARS-CoV-2 virus evade the immune system.

The key insight making this possible is that many properties of biological systems can be interpreted in terms of words and sentences. More...
In the last few years, a handful of researchers have shown that protein sequences and genetic codes can be modeled using NLP techniques. Now, computational biologists at the Massachusetts Institute of Technology (MIT; Cambridge, MA, USA) have pulled several of these strands together and use NLP to predict mutations that allow viruses to avoid being detected by antibodies in the human immune system, a process known as viral immune escape. The basic idea is that the interpretation of a virus by an immune system is analogous to the interpretation of a sentence by a human.

The team uses two different linguistic concepts: grammar and semantics (or meaning). The genetic or evolutionary fitness of a virus - characteristics such as how good it is at infecting a host - can be interpreted in terms of grammatical correctness. A successful, infectious virus is grammatically correct; an unsuccessful one is not. Similarly, mutations of a virus can be interpreted in terms of semantics. Mutations that make a virus appear different to things in its environment - such as changes in its surface proteins that make it invisible to certain antibodies - have altered its meaning. Viruses with different mutations can have different meanings, and a virus with a different meaning may need different antibodies to read it.

To model these properties, the researchers used an LSTM, a type of neural network that predates the transformer-based ones used by large language models like GPT-3. These older networks can be trained on far less data than transformers and still perform well for many applications. Instead of millions of sentences, they trained the NLP model on thousands of genetic sequences taken from three different viruses: 45,000 unique sequences for a strain of influenza, 60,000 for a strain of HIV, and between 3,000 and 4,000 for a strain of the SARS-CoV-2 virus.

NLP models work by encoding words in a mathematical space in such a way that words with similar meanings are closer together than words with different meanings. This is known as an embedding. For viruses, the embedding of the genetic sequences grouped viruses according to how similar their mutations were. The overall aim of the approach is to identify mutations that might let a virus escape an immune system without making it less infectious - that is, mutations that change a virus’s meaning without making it grammatically incorrect.

To test their approach, the team used a common metric for assessing predictions made by machine-learning models that scores accuracy on a scale between 0.5 (no better than chance) and 1 (perfect). In this case, they took the top mutations identified by the tool and, using real viruses in a lab, checked how many of them were actual escape mutations. Their results ranged from 0.69 for HIV to 0.85 for one coronavirus strain. This is better than results from other state-of-the-art models, according to the researchers.

The team has been running models on new variants of the coronavirus, including the so-called UK mutation, the mink mutation from Denmark, and variants taken from South Africa, Singapore and Malaysia. Using NLP accelerates a slow process. Previously, the genome of the virus taken from a COVID-19 patient in hospital could be sequenced and its mutations re-created and studied in a lab. However, that can take weeks, whereas the NLP model predicts potential mutations straight away, which focuses the lab work and speeds it up.

“We’re learning the language of evolution,” said Bonnie Berger, a computational biologist at the Massachusetts Institute of Technology. “Biology has its own language.”

Related Links:
Massachusetts Institute of Technology (MIT)


Gold Member
Multiplex Genetic Analyzer
MassARRAY Dx Analyzer (Europe only)
Portable Electronic Pipette
Mini 96
Gold Member
Automatic Hematology Analyzer
DH-800 Series
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.